Acadia Pharmaceuticals did not disclose the buyer of the priority review voucher. The biotech received the voucher last year alongside the regulatory decision that made its drug Daybue the first ...

Acadia Pharmaceuticals did not disclose the buyer of the priority review voucher. The biotech received the voucher last year alongside the regulatory decision that made its drug Daybue the first ...

Ann Arbor, Michigan, biopharmaceutical company Cerenis Therapeutics added $13.9 million to a July investment round that it will use to continue clinical trials of a drug to treat heart disease.

Generative artificial intelligence has taken the world by storm. At the snap of a finger, or a few clacks on the keyboard, anyone with internet access can conjure up academic essays, legal ...

As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...